Search | Clinical Trials Finder

These results were retrieved from the live ClinicalTrials.gov registry. Filters and sort order apply to this result list.

ClinicalTrials.gov public records Last synced Nov 7, 2026, 12:12 PM EST

All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.

Showing 1705–1728 of 8,271 matching trials from the live ClinicalTrials.gov search.

Filters: Intervention: Age Clear all

Conditions: Critical Illness, Pain, Delirium, Confusion
Interventions: Video Monitoring, Accelerometer Monitoring, Noise Level Monitoring, Light Level Monitoring, Air Quality Monitoring, EKG Monitoring, Vitals Monitoring, Biosample Collection, Delirium Motor Subtyping Scale 4 (DMSS-4); Other
Lead sponsor: University of Florida; Other
Eligibility: 18 Years and older
Enrollment: 400 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2021 – 2026
U.S. locations: 1
States / cities: Gainesville, Florida

Conditions: Eating Disorder
Interventions: The Body Project: More Than Muscles; Behavioral
Lead sponsor: Florida State University; Other
Eligibility: 18 Years to 30 Years · Male only
Enrollment: 112 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2014 – 2015
U.S. locations: 1
States / cities: Tallahassee, Florida

Conditions: Normal Physiology
Interventions: Pupillometry, Light box exposure; Device
Lead sponsor: Massachusetts General Hospital; Other
Eligibility: 18 Years to 85 Years
Enrollment: 48 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Behavior Problem, Mental Disorder, Emotional Problem
Interventions: Family Centered Treatment, Level II or Level III Out of Home Placement; Behavioral
Lead sponsor: Duke University; Other
Eligibility: 5 Years to 17 Years
Enrollment: 750 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2018 – 2027
U.S. locations: 2
States / cities: Charlotte, North Carolina • Elkin, North Carolina

Conditions: Irritability Associated With Autism Spectrum Disorder
Interventions: KarXT, KarX-EC, KarXT + KarX-EC Matching Placebo; Drug
Lead sponsor: Bristol-Myers Squibb; Industry
Eligibility: 5 Years to 17 Years
Enrollment: 176 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2026 – 2029
U.S. locations: 23
States / cities: Phoenix, Arizona • Glendale, California • Los Angeles, California + 19 more

Conditions: Cancer, Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm
Interventions: Physical Activity; Behavioral
Lead sponsor: Mayo Clinic; Other
Eligibility: 18 Years and older
Enrollment: 100 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2025
U.S. locations: 4
States / cities: Albert Lea, Minnesota • Mankato, Minnesota • Eau Claire, Wisconsin + 1 more

Conditions: Diabetes Complications, Diabetic Retinopathy
Interventions: Generation of inducible pluripotent stem cells; Biological
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 21 Years to 98 Years
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2018 – 2027
U.S. locations: 1
States / cities: Birmingham, Alabama

Conditions: COVID-19
Interventions: SARS-CoV-2 rS/Matrix-M1 Adjuvant (Initial Vaccination Period), Placebo; Biological · Other
Lead sponsor: Novavax; Industry
Eligibility: 6 Months to 11 Years
Enrollment: 3,600 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2025
U.S. locations: 47
States / cities: Little Rock, Arkansas • Anaheim, California • Bellflower, California + 41 more

Conditions: PreDiabetes, Obesity, Inactivity/Low Levels of Exercise
Interventions: AM Exercise, PM Exercise; Behavioral
Lead sponsor: University of Colorado, Denver; Other
Eligibility: 20 Years to 40 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2024 – 2026
U.S. locations: 1
States / cities: Aurora, Colorado

Conditions: Staphylococcal Skin Infection, Abscess, Furunculosis, Staphylococcus Aureus, MRSA Infection
Interventions: 2% mupirocin ointment, Bleach Bath (dilute), Hygiene Protocol; Drug · Other · Behavioral
Lead sponsor: Washington University School of Medicine; Other
Eligibility: Not listed
Enrollment: 474 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2013 – 2017
U.S. locations: 1
States / cities: St Louis, Missouri

Conditions: Scoliosis, Pectus Excavatum
Interventions: Hypnosis; Behavioral
Lead sponsor: Nationwide Children's Hospital; Other
Eligibility: 10 Years to 21 Years
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2016
U.S. locations: 1
States / cities: Columbus, Ohio

Conditions: SARS-CoV-2, Influenza, RSV
Interventions: mRNA-1010, mRNA-1345, mRNA-1273.214, mRNA-1045, mRNA-1230; Biological
Lead sponsor: ModernaTX, Inc.; Industry
Eligibility: 50 Years to 75 Years
Enrollment: 392 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 14
States / cities: DeLand, Florida • Hollywood, Florida • St. Petersburg, Florida + 11 more

Conditions: Coccidioidomycosis, Pneumonia
Interventions: Not listed
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 14 Years to 99 Years
Enrollment: 651 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2019 – 2023
U.S. locations: 6
States / cities: Phoenix, Arizona • Tucson, Arizona • Bakersfield, California + 2 more

Conditions: Pain
Interventions: Methadone HCl Inject 10 mg/ml (will require dilution), Methadone; Drug
Lead sponsor: University of Utah; Other
Eligibility: 29 Weeks to 48 Weeks
Enrollment: 7 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2017
U.S. locations: 2
States / cities: Salt Lake City, Utah

Conditions: Influenza
Interventions: Trivalent inactivated influenza vaccine; Biological
Lead sponsor: National Institute of Allergy and Infectious Diseases (NIAID); NIH
Eligibility: 18 Years to 64 Years
Enrollment: 102 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2011 – 2013
U.S. locations: 1
States / cities: Iowa City, Iowa

Conditions: Infant Nutrition
Interventions: Standard infant formula, Infant formula with different level of proteins; Other
Lead sponsor: Société des Produits Nestlé (SPN); Industry
Eligibility: 3 Months to 12 Months
Enrollment: 405 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2008 – 2015
U.S. locations: 2
States / cities: Iowa City, Iowa • Oklahoma City, Oklahoma

Conditions: Autism, Autism Spectrum Disorder
Interventions: Not listed
Lead sponsor: Duke University; Other
Eligibility: 16 Months to 36 Months
Enrollment: 350 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2027
U.S. locations: 1
States / cities: Durham, North Carolina

Conditions: Chronic Stress, Systemic Inflammation, Mobility and Independence
Interventions: Eutectogel Sensors and Microneedle Patches; Device
Lead sponsor: Tufts University; Other
Eligibility: 65 Years and older
Enrollment: 20 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2025 – 2028
U.S. locations: 1
States / cities: Boston, Massachusetts

Conditions: Sleep Quality, Compliance, Physical Activity, Sedentary Behaviors, Sleep Duration
Interventions: Time Restricted Eating, Control; Behavioral
Lead sponsor: University of Georgia; Other
Eligibility: 18 Years to 26 Years · Female only
Enrollment: 36 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2026 – 2027
U.S. locations: 1
States / cities: Athens, Georgia

Conditions: Cataract
Interventions: Aspheric Acrysof ReSTOR intraocular lens; Device
Lead sponsor: Medical University of South Carolina; Other
Eligibility: 40 Years to 90 Years
Enrollment: 20 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2007 – 2008
U.S. locations: 1
States / cities: Charleston, South Carolina

Conditions: Post Partum Pre-eclampsia
Interventions: no intervention; Other
Lead sponsor: Duke University; Other
Eligibility: 18 Years to 65 Years · Female only
Enrollment: 12 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2017 – 2022
U.S. locations: 2
States / cities: New York, New York • Durham, North Carolina

Conditions: Prematurity
Interventions: Human milk; Dietary Supplement
Lead sponsor: University of Alabama at Birmingham; Other
Eligibility: 6 Hours to 4 Days
Enrollment: 486 participants
Healthy volunteers: Healthy volunteers not accepted
Timeline: 2025 – 2030
U.S. locations: 4
States / cities: Birmingham, Alabama • Jackson, Mississippi • Dallas, Texas + 1 more

Conditions: Measles; Mumps; Rubella; Chickenpox, Measles
Interventions: Investigational MMRV(H)NS vaccine, Investigational MM(H)RVNS vaccine, Investigational M(L)M(L)R(L)V(L)NS vaccine, Marketed MMRV_Lot 1 and Lot 2 vaccine; Biological
Lead sponsor: GlaxoSmithKline; Industry
Eligibility: 4 Years to 6 Years
Enrollment: 801 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2022 – 2024
U.S. locations: 35
States / cities: Birmingham, Alabama • Jonesboro, Arkansas • Bellflower, California + 30 more

Conditions: Immunization, HPV Infection, Human Papillomavirus
Interventions: 9-valent HPV vaccine, 2 doses alternate timing, 9-valent HPV vaccine, 3 doses standard timing; Biological
Lead sponsor: The University of Texas Medical Branch, Galveston; Other
Eligibility: 27 Years to 45 Years · Female only
Enrollment: 618 participants
Healthy volunteers: Accepts healthy volunteers
Timeline: 2023 – 2028
U.S. locations: 1
States / cities: Galveston, Texas

Search by objective public record fields.

Pervasive Sensing and AI in Intelligent ICU

Reducing Eating Disorder Risk Factors Among College-Aged Males

Impact of Sex and Age on Non-visual Light Input That Affects Sleep and Circadian Rhythms

FCT Study: Reducing the Need for Out-of-Home Placements

A Study of KarXT + KarX-EC for Treatment of Irritability in Children and Adolescents With Autism Spectrum Disorder

A Study of Physical Activity in Cancer Survivors

Human iPSC for Repair of Vasodegenerative Vessels in Diabetic Retinopathy

Study to Evaluate Safety and Immunogenicity of COVID-19 Vaccine in Children 6 Months to < 12 Years

Examining the Effects of Morning and Evening Exercise on Glucose Regulation in Adults With Prediabetes

Individualized vs. Household MRSA Decolonization

Hypnotherapy in Major Surgical Procedures

A Safety, Reactogenicity, and Immunogenicity Study of mRNA-1045 (Influenza and Respiratory Syncytial Virus [RSV]) or mRNA-1230 (Influenza, RSV, and Severe Acute Respiratory Syndrome Coronavirus 2 [SARS-CoV-2]) Vaccine in Adults 50 to 75 Years Old

An Observational Study to Assess the Prevalence and Outcomes of Primary Pulmonary Coccidioidomycosis in Persons Aged > / = 14 Years Presenting With Community Acquired Pneumonia (CAP) in Endemic Areas (SAnds-PPC)

Methadone Pharmacokinetics and Cardiac Effects in Newborns

TIV and High Dose TIV in Subjects With Rheumatoid Arthritis

Effect of the Level of Dietary Protein on Infant Growth

SenseToKnow Autism Screening Device Validation Study

Assessing the Feasibility of Multi-modal Biosensing for Monitoring Mobility and Cognition in Older Adults

Changes in 24-hour Activity Cycle Behaviors During a Time-Restricted Eating Intervention in College-Aged Women

Evaluation of the Aspheric ReSTOR IOL After Routine Cataract Extraction

Characterization and Epigenetics of Post-Partum Preeclampsia

Milk And Growth In Children (MAGIC) Born Very Preterm: A Randomized Trial

A Study on the Immune Response and Safety of a Combined Measles, Mumps, Rubella, Chickenpox Vaccine Compared to a Marketed Combined Vaccine, Given to Healthy Children 4 to 6 Years of Age

Comparing Immune Response of 2 vs 3 HPV Doses (27-45 Years Old)